2020
DOI: 10.1016/j.resuscitation.2020.10.010
|View full text |Cite
|
Sign up to set email alerts
|

Refibrillation after defibrillation: The shocking truth

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…For example, one strategy might use the algorithm to provide earlier or higher-dose antiarrhythmic treatment or a lower or delayed dose of a vasopressor such as epinephrine (given its potential proarrhythmic effects) for those at high risk of refractory VF. [8][9][10][11][12][13][14][15] The algorithm might also be used to inform which patients could be considered for modified shock delivery strategies (vector change or double sequential defibrillation) or early transport for advanced hospital care such as an emergent coronary artery intervention or extracorporeal CPR. [16][17][18][19][20][21]…”
Section: Clinical Implications Of Algorithm Performancementioning
confidence: 99%
See 1 more Smart Citation
“…For example, one strategy might use the algorithm to provide earlier or higher-dose antiarrhythmic treatment or a lower or delayed dose of a vasopressor such as epinephrine (given its potential proarrhythmic effects) for those at high risk of refractory VF. [8][9][10][11][12][13][14][15] The algorithm might also be used to inform which patients could be considered for modified shock delivery strategies (vector change or double sequential defibrillation) or early transport for advanced hospital care such as an emergent coronary artery intervention or extracorporeal CPR. [16][17][18][19][20][21]…”
Section: Clinical Implications Of Algorithm Performancementioning
confidence: 99%
“…[5][6][7] Hence, the ability to predict refractory VF in advance of repeated shock failure could enable preemptive interventions targeted at improving the relatively poor outcomes of the refractory VF subgroup. Such therapies might include earlier or increased antiarrhythmic dose administration, [8][9][10][11][12] reconsideration of epinephrine use or dosage, [13][14][15] changes in how shocks are administered, 16 or expedited invasive interventions. [17][18][19][20][21] By contrast, empiric treatment of all patients with VF OHCA using such strategies may unnecessarily expose patients who achieve best outcomes under the current protocol, introducing potential risk among those unlikely to benefit.…”
mentioning
confidence: 99%